An Enhanced Artificial Intelligence Breast MRI Scanning System (IntelliScan)

“乳腺癌是全世界女性最常见的癌症类型，2015年有近170万新确诊病例(总体排名第二的常见癌症)。这约占所有新发癌症病例的12%，占所有女性癌症病例的25%。根据世界卫生组织(Global Heath Estiments 2013)的数据，超过50%的乳腺癌病例和42%的死亡病例发生在发达国家。这包括英国，在英国，五分之一的乳腺癌病例会导致死亡。因此，该项目寻求开发INTELLISCAN，这是一种人工智能、机器学习增强的乳腺MRI扫描系统，用作高效、更准确的乳腺癌筛查工具。我们的技术应用基于计算机的图像处理，为乳腺MRI扫描提供改进的、即时的、自动的异常检测。“

"Breast cancer is the most common type of cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2015 (second most common cancer overall). This represents about 12% of all new cancer cases and 25% of all cancers in women. According to the World Health Organisation (Global Heath Estimates 2013), over 50% of breast cancer cases and 42% of deaths occur in developed countries. This includes the UK, where one in 5 cases of breast cancer results in a fatality.This project therefore seeks to develop INTELLISCAN, an Artificial Intelligence, machine learning enhanced breast MRI scanning system for use as a highly efficient, more accurate breast cancer screening tool. Our technology applies computer based image processing to deliver improved, instant, automated anomaly detection of breast MRI scans. "